Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-31 @ 8:25 PM
Study NCT ID:
NCT02141204
Status:
COMPLETED
Last Update Posted:
2020-12-09
First Post:
2014-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-15
First Submit QC Date:
None
Study First Post Date:
2014-05-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-11-12
Results First Submit QC Date:
None
Results First Post Date:
2020-12-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-12
Last Update Post Date:
2020-12-09
Last Update Post Date Type:
ACTUAL